Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2007;115:1858-1865
Published online before print March 26, 2007, doi: 10.1161/CIRCULATIONAHA.106.679985
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
Circulation: April 10, 2007, Volume 115, Number 14
Right arrow All Versions of this Article:
115/14/1858    most recent
CIRCULATIONAHA.106.679985v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow patientINFORMation
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sun, Q.
Right arrow Articles by Hu, F. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sun, Q.
Right arrow Articles by Hu, F. B.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Heart Attack
Related Collections
Right arrow Nutrition
Right arrow Acute myocardial infarction
Right arrow Epidemiology
Right arrowRelated Article

(Circulation. 2007;115:1858-1865.)
© 2007 American Heart Association, Inc.


Coronary Heart Disease

A Prospective Study of Trans Fatty Acids in Erythrocytes and Risk of Coronary Heart Disease

Qi Sun, MD; Jing Ma, MD, PhD; Hannia Campos, PhD; Susan E. Hankinson, ScD; JoAnn E. Manson, MD, DrPH; Meir J. Stampfer, MD, DrPH; Kathryn M. Rexrode, MD, MPH; Walter C. Willett, MD, DrPH; Frank B. Hu, MD, PhD

From the Departments of Nutrition (Q.S., H.C., M.J.S., W.C.W., F.B.H.) and Epidemiology (Q.S., S.E.H., J.E.M., M.J.S., W.C.W., F.B.H), Harvard School of Public Health; Channing Laboratory (J.M., S.E.H., J.E.M., M.J.S., W.C.W., F.B.H.) and Division of Preventive Medicine (J.E.M., M.J.S., K.M.R., W.C.W.), Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Mass.

Correspondence to Frank B. Hu, MD, PhD, Department of Nutrition, Harvard School of Public Health, 665 Huntington Ave, Boston, MA 02115. E-mail frank.hu{at}channing.harvard.edu

Received November 29, 2006; accepted January 24, 2007.

Background— High consumption of trans fat has been linked to the risk of coronary heart disease (CHD). We assessed the hypothesis that higher trans fatty acid contents in erythrocytes were associated with an elevated risk of CHD in a nested case-control study among US women.

Methods and Results— Blood samples were collected from 32 826 participants of the Nurses’ Health Study from 1989 to 1990. During 6 years of follow-up, 166 incident cases of CHD were ascertained and matched with 327 controls. Total trans fatty acid content in erythrocytes was significantly correlated with dietary intake of trans fat (correlation coefficient=0.44, P<0.01) and was associated with increased plasma low-density lipoprotein cholesterol (P for trend =0.06), decreased plasma high-density lipoprotein cholesterol concentrations (P for trend <0.01), and increased plasma low-density lipoprotein to high-density lipoprotein ratio (P for trend <0.01). After adjustment for age, smoking status, and other dietary and lifestyle cardiovascular risk factors, higher total trans fatty acid content in erythrocytes was associated with an elevated risk of CHD. The multivariable relative risks (95% confidence intervals) of CHD from the lowest to highest quartiles of total trans fatty acid content in erythrocytes were 1.0 (reference), 1.6 (0.7 to 3.6), 1.6 (0.7 to 3.4), and 3.3 (1.5 to 7.2) (P for trend <0.01). The corresponding relative risks were 1.0, 1.1, 1.3, and 3.1 (P for trend <0.01) for a total of 18:1 trans isomers and 1.0, 1.5, 2.5, and 2.8 (P for trend <0.01) for a total of 18:2 trans isomers.

Conclusions— These biomarker data provide further evidence that high trans fat consumption remains a significant risk factor for CHD after adjustment for covariates.


 

CLINICAL PERSPECTIVE


Find additional patient-related information at:

A Prospective Study of Trans Fatty Acids in Erythrocytes and Risk of Coronary Heart Disease

Related Article:

Issue Highlights
Circulation 2007 115: 1823. [Extract] [Full Text]



This article has been cited by other articles:


Home page
BMJHome page
Q. Sun, M. K Townsend, O. I Okereke, O. H Franco, F. B Hu, and F. Grodstein
Adiposity and weight change in mid-life in relation to healthy survival after age 70 in women: prospective cohort study
BMJ, September 29, 2009; 339(sep29_1): b3796 - b3796.
[Abstract] [Full Text] [PDF]


Home page
AMERICAN JOURNAL OF LIFESTYLE MEDICINEHome page
S. S. Bassuk and J. E. Manson
Lifestyle and Risk of Cardiovascular Disease and Type 2 Diabetes in Women: A Review of the Epidemiologic Evidence
American Journal of Lifestyle Medicine, June 1, 2008; 2(3): 191 - 213.
[Abstract] [PDF]


Home page
Am J EpidemiolHome page
V. Chajes, A. C. M. Thiebaut, M. Rotival, E. Gauthier, V. Maillard, M.-C. Boutron-Ruault, V. Joulin, G. M. Lenoir, and F. Clavel-Chapelon
Association between Serum trans-Monounsaturated Fatty Acids and Breast Cancer Risk in the E3N-EPIC Study
Am. J. Epidemiol., June 1, 2008; 167(11): 1312 - 1320.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
A. Motard-Belanger, A. Charest, G. Grenier, P. Paquin, Y. Chouinard, S. Lemieux, P. Couture, and B. Lamarche
Study of the effect of trans fatty acids from ruminants on blood lipids and other risk factors for cardiovascular disease
Am. J. Clinical Nutrition, March 1, 2008; 87(3): 593 - 599.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
E. K. Kabagambe, M. Y. Tsai, P. N. Hopkins, J. M. Ordovas, J. M. Peacock, I. B. Borecki, and D. K. Arnett
Erythrocyte Fatty Acid Composition and the Metabolic Syndrome: A National Heart, Lung, and Blood Institute GOLDN Study
Clin. Chem., January 1, 2008; 54(1): 154 - 162.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. A. Spector and W. G. Haynes
LDL Cholesteryl Oleate: A Biomarker for Atherosclerosis?
Arterioscler Thromb Vasc Biol, June 1, 2007; 27(6): 1228 - 1230.
[Full Text] [PDF]